The Value of a Multi-Source Real-World Data Strategy: How to Overcome Gaps and Limitations

Sponsored by:

Date:

April 7, 2021

Duration (min):

Syapse experts Anna Berry, Mary Tran, and Michael Italia share how to establish high quality, real-world datasets by using a multi-source strategy.

A single source of data is often not enough to generate meaningful real-world evidence. Have you recently made an investment in a large raw real-world dataset, and are now drowning in data but lacking in evidence?

Watch as experts highlight strategic approaches you and your organization should consider as you invest in RWD to best capture the comprehensive patient journey needed to answer your most challenging questions, or seek to validate real-world endpoints.

Presenters

Anna Berry

Syapse (Molecular Pathology, Genomics and Laboratory Medicine)

Vice President

Dr. Anna Berry is a thought leader in molecular oncology and personalized medicine, and experienced Scientific and Medical Director with a demonstrated history of working in the hospital & health care industry. Skilled in Oncology, Molecular Oncology, Molecular Biology, Healthcare Information Technology (HIT), and Healthcare Management.

Mary Tran

Syapse (Data Insights)

Vice President

Mary Tran is a healthcare strategist working to elevate the quality, delivery, and value of healthcare globally. She has diverse experience with change agents across the healthcare market, including clinical providers, system administrators, public officials, medical associations, payers, and industry (pharma, devices, and diagnostics).

Michael Italia

Syapse (Product Development)

Vice President

Michael Italia is focused on oncology precision medicine and real world evidence as VP of Product Development for Syapse. He leads teams to design and build complex, data-centric software applications in life science and healthcare.

Syapse

Advancing care requires real insights and collaboration. At Syapse, we start by analyzing real-world data to generate deep, quality insights that improve outcomes for all people with cancer.

Content Partners

HealthEconomics.com

HealthEconomics.com is the world’s largest Connected Community™ for Value, Evidence and Access in the life sciences industry.

HealthEconomics.com provides a single global link to the health economic and outcomes research (HEOR), real-world evidence (RWE), and Market Access (MA) stakeholder communities. Since 1993, we have provided unparalleled access to drive business, improve knowledge, and connect researchers and payer decision-makers world-wide.

Our 27,000 engaged readers rely on HealthEconomics.com as the most reliable, credible and curated digital hub for the latest news, insights, educational opportunities, and industry benchmarks in HEOR, RWE and MA. Our advertisers, numbering more than 500 with a 91% retention rate, depend upon HealthEconomics.com for best-in-class global brand awareness and business development solutions. Our aim is to connect people with expert-driven content and resources — all in one place — with the corporate mission to advance communication about healthcare value.

Topics

Real-World Data (RWD)

Real-World Evidence (RWE)

The Value of a Multi-Source Real-World Data Strategy: How to Overcome Gaps and Limitations

Presenters

Anna Berry

Mary Tran

Michael Italia

Sponsor

Syapse

Content Partners

HealthEconomics.com

Topics

Watch Now

Related Content

From Clinical Data to Actionable Assets for Pharmaceutical R&D

Closing Gaps in Care: Health Equity and the Inflation Reduction Act - A Cutting Edge Conversation

Addressing Orphan and Rare Diseases - A Cutting Edge Conversation

Closing Gaps in Care: Health Equity and the Inflation Reduction Act - A Cutting Edge Conversation

From Clinical Data to Actionable Assets for Pharmaceutical R&D

RWE reality check: Routine patient health records and regulatory requirements

"S" Stands for Systematic: Demystifying the Systematic Literature Review

The Scientific and Operational Elegance of Study Replication with Real-World EHR Data: A Vitiligo and Alopecia Example

Practical AI: Adding Insight to the Patient Journey with Digital Phenotyping

Insights from the 2024 Salary Survey Report by HealthEconomics.com

Beyond Accelerated Approvals: External Control Arms

Delphi Panels: What Are They Good For?

Integrated Evidence Generation Planning: Driving Successful Reimbursement and Life Cycle Management

Patient Voices Matter: Transforming Industry-Sponsored Real-World Evidence with Patient-Centric Approaches

Navigating the Clinical Outcomes Maze: An Overview of Clinical Outcomes Assessments and Why Training Matters

Bridging the Gap: Strategies for Patient-Centered Real-World Evidence in Rare Diseases

The role of patient-centric technologies & tokenization in RWE studies

How to assess the quality of AI output when structuring unstructured medical data

Transforming clinical research: Scaling real-world data across diseases with expert-led AI

Synthesise RWE and AI. Transform patient-driven healthcare

Notice of Pre-Application Webinar for RFA-AG-24-009, "Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) Real-World Data Platform (U54 Clinical Trial Optional)"

Patient Data: Opportunities for Rare Diseases, Cell and Gene Therapies, and Oncology

Connecting Real-World Data and Domain Expertise to Enhance Trial Design and Planning

Pairing quality genomic data with longitudinal patient records

Keeping pace with the evolving global landscape in vaccine development

Improving Treatment Access & Outcomes by Integrating Social Determinants of Health Data with Real-World Evidence

How to Supercharge Real World Evidence Generation in Phase IV Trials

HEOR Writing: The Ins and Outs of Value Communications

The Future of Real-World Evidence: Pharma's Next Moves, Upcoming Webinar Hosted by Xtalks

Digital therapeutics: Software is now entering mainstream therapeutic care

Longitudinal Patient Data - Addressing Common Questions & Unlocking the Value of Real-World Data, Upcoming Webinar Hosted by Xtalks

Workshop: Harnessing the Power of EHR Data and AI to Advance Biomedical Research

Addressing Common Research Questions with Real World Data Best Practices

Optimize Your Decentralized Clinical Trials with Real-World Data

Real World Evidence for COVID-19: Making an impact now and into the future

Patient-Centric RWE Research & Remote Monitored Care: Learnings from a support program leveraging telehealth & connected devices

Marketplaces Drive Faster Science: HEOR, RWE & Market Access Sourcing

Partnering with Disease Registries: The Value and Impact for Real-World Evidence Generation

Improving Patient Outcomes: AI-Based Phenotyping for Diagnosis, Treatment, and Clinical Trials

What Every Researcher Needs to Know About Using Medicare Data for Real World Evidence

Medicare Part D: Price Negotiation Panel Discussion

Finding Value in Linking Real-World Data with Social Determinants of Health

Economic Impact of Representativeness in Clinical Trials: How Real-World Data Can Help

Designing Causal Inference Studies Using Real-World Data

Social Media Data: Opportunities and Insights for Clinical Research

Accelerating the Generation of Payer Insights and Evidence Across the Product Lifecycle to Achieve Optimal Access

Achieving Consensus When Everyone is an Expert, but No One Agrees

An Introduction to Infectious Disease Modeling

Syapse Real-World Dialogue: Advancing Patient Care through Real-World Data, Machine Learning, and Systems Biology

Evidence Synthesis for Sparse Evidence Base, Heterogeneous Studies, and Disconnected Networks

Optimize Your Value Story Through Integrated Evidence Generation - From Bench to Patient

Using Real-World Data to Explore and Demonstrate Comparative Effectiveness

Informing Market Access Earlier in Clinical Development: Prospective RWE Research to Characterize Real World Patient Populations

FDA Guidance Documents: Shaping the Future of RWD Curation and RWE Innovation

Data Integrity in Decentralized Clinical Trials (DCTs)

How Cerner Enviza Uses Clinical Data to Drive RWE Decisions

Cracking the Code: When and How to Validate ICD Algorithms for RWE

Optimizing Real-World Evidence for Maternal and Neonatal Outcomes

How Literature Review Automation and Efficient Processes Streamline RWE HEOR Studies

Cutting Edge Conversations: Addressing Orphan and Rare Diseases

Overcoming Clinical Research Challenges: Analyzing EHR Data to Replicate Clinical Trials and Construct External Control Arms